Predictive value of MAOB gene expression for targeted therapy in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB (Alliance)/SWOG 80405.

Authors

null

Wu Zhang

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Wu Zhang , Joshua Millstein , Yan Yang , Fang-Shu Ou , Federico Innocenti , Hiroyuki Arai , Shivani Soni , Shannon M. Mumenthaler , Sandra Algaze , Priya Jayachandran , Monica M. Bertagnolli , Dustin A. Deming , Donna Niedzwiecki , Richard M. Goldberg , Robert J. Mayer , Charles David Blanke , Alan P. Venook , Omar Kabbarah , Francesca Battaglin , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3580)

DOI

10.1200/JCO.2022.40.16_suppl.3580

Abstract #

3580

Poster Bd #

374

Abstract Disclosures